Case details

Court: ded
Docket #: 1:16-cv-00954
Case Name: Astellas Pharma Inc. et al v. Sawai Pharmaceutical Co., Ltd. et al
PACER case #: 60496
Date filed: 2016-10-17
Assigned to: Judge Sue L. Robinson
Case Cause: 35:271 Patent Infringement
Nature of Suit: 830 Patent
Jury Demand: Defendant
Jurisdiction: Federal Question

Parties

Represented Party Attorney & Contact Info
Astellas Pharma Inc.
Counter Defendant
Jack B. Blumenfeld
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Maryellen Noreika
(See above for address)
ATTORNEY TO BE NOTICED

Astellas Ireland Co., Ltd.
Counter Defendant
Jack B. Blumenfeld
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Maryellen Noreika
(See above for address)
ATTORNEY TO BE NOTICED

Astellas Pharma Global Development, Inc.
Counter Defendant
Jack B. Blumenfeld
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Maryellen Noreika
(See above for address)
ATTORNEY TO BE NOTICED

Sawai Pharmaceutical Co., Ltd.
Counter Claimant
Dominick T. Gattuso
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Brian J. Sodikoff
(See above for address)
ATTORNEY TO BE NOTICED

Christopher B. Ferenc
(See above for address)
ATTORNEY TO BE NOTICED

Martin S. Masar , III
(See above for address)
ATTORNEY TO BE NOTICED

Sawai USA, Inc.
Counter Claimant
Dominick T. Gattuso
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Documents

Date Filed Document # Attachment # Short Description Long Description Upload date SHA1 hash
2016-10-17 1 0 COMPLAINT for Patent Infringement filed against Sawai Pharmaceutical Co., Ltd., Sawai USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2014248.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(sar) (Entered: 10/17/2016)
2016-10-17 2 0 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) (Entered: 10/17/2016)
2016-10-17 3 0 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/13/16. Date of Expiration of Patent: (SEE LIST).Thirty Month Stay Deadline: 12/28/2019. (sar) (Entered: 10/17/2016)
2016-10-17 4 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,346,532 B1; 7,342,117 B2; 7,982,049 B2; 8,835,474 B2; RE44,872 E;. (sar) (Entered: 10/17/2016)
2016-10-17 5 0 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd.; Corporate Parent Astellas US Holding, Inc. for Astellas Pharma Global Development, Inc. filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (sar) (Entered: 10/17/2016)
2016-10-19 6 0 SUMMONS Returned Executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. Sawai USA, Inc. served on 10/18/2016, answer due 11/8/2016. (Noreika, Maryellen) (Entered: 10/19/2016)
2016-11-03 7 0 MOTION for Pro Hac Vice Appearance of Attorney Robert L. Baechtold, John D. Murnane, Simon D. Roberts, and Christopher P. Borello - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development Inc., Astellas Pharma Inc., Astellas Pharma Global Development, Inc.. (Noreika, Maryellen) (Entered: 11/03/2016)
2016-11-14 8 0 REQUEST FOR WAIVER of Service sent to Sawai Pharmaceutical Co., Ltd. on October 26, 2016 by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. Waiver of Service due by 11/25/2016. (Noreika, Maryellen) (Entered: 11/14/2016)
2016-11-14 9 0 WAIVER OF SERVICE returned executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.: For Sawai Pharmaceutical Co., Ltd. waiver sent on 10/26/2016, answer due 12/27/2016. (Noreika, Maryellen) (Entered: 11/14/2016)
2016-11-14 10 0 STIPULATION TO EXTEND TIME for defendants to move, answer, or otherwise respond to the Complaint to January 17, 2017 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Noreika, Maryellen) (Entered: 11/14/2016)
2016-12-14 11 0 ORDER, IT IS ORDERED that, on or before Wednesday, December 28, 2016, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 12/28/2016.) Signed by Judge Sue L. Robinson on 12/14/2016. Associated Cases: 1:16-cv-00905-SLR et al.(nmfn) (Entered: 12/14/2016)
2016-12-16 12 0 MOTION for Pro Hac Vice Appearance of Attorney Brian Sodikoff, Martin S. Masar III, and Christopher B. Ferenc - filed by Sawai Pharmaceutical Co., Ltd., Sawai USA, Inc.. (Gattuso, Dominick) (Entered: 12/16/2016)
2016-12-28 13 0 Letter to The Honorable Sue L. Robinson from Jack B. Blumenfeld regarding consolidated discovery and consolidated Markman proceedings - re (13 in 1:16-cv-00976-SLR, 13 in 1:16-cv-00976-SLR) Order,, Set Deadlines,. (Blumenfeld, Jack) (Entered: 12/28/2016)
2017-01-06 14 0 Order Setting In-Person Patent Scheduling Conference: A Scheduling Conference is set for 2/22/2017 at 04:00 PM in Courtroom 4B before Judge Sue L. Robinson. Signed by Judge Sue L. Robinson on 1/6/2017. Associated Cases: 1:16-cv-00905-SLR et al.(nmfn) (Entered: 01/06/2017)
2017-01-06 15 0 STIPULATION TO EXTEND TIME regarding answer and counterclaims to January 17, 2017 for Defendants' response to the Complaint; February 21, 2017 for Plaintiffs' response to counterclaims filed on or before January 17 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Noreika, Maryellen) (Entered: 01/06/2017)
2017-01-17 16 0 ANSWER to 1 Complaint, with Jury Demand , COUNTERCLAIM against Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. by Sawai USA, Inc., Sawai Pharmaceutical Co., Ltd..(Gattuso, Dominick) (Entered: 01/17/2017) 2017-01-18 10:40:22 4c65476e5d6be251ff8d6065de01323a56f214e1
2017-01-17 17 0 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sawai Pharmaceutical Co., Ltd. for Sawai USA, Inc. filed by Sawai Pharmaceutical Co., Ltd., Sawai USA, Inc.. (Gattuso, Dominick) (Entered: 01/17/2017)